KANSAS U COBRE: GERM CELL DEVELOPMENT IN THE ATRICHOSIS MUTANT MOUSE
KANSAS U COBRE:无生长突变小鼠生殖细胞的发育
基本信息
- 批准号:8167984
- 负责人:
- 金额:$ 22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:Cell CommunicationCellsClinicalClinical ProtocolsComputer Retrieval of Information on Scientific Projects DatabaseDefectDevelopmentDevelopmental BiologyFertilityFundingGenesGeneticGenital systemGerm CellsGoalsGrantHistologyHumanInfertilityInstitutionKansasMale InfertilityMutant Strains MicePatientsProliferatingResearchResearch PersonnelResourcesSertoli cell only syndromeSourceStructure of primordial sex cellTestingTestisUnited States National Institutes of HealthWorkcell motilitygain of functionhuman maleloss of functionmalemouse modelmutantrestorationsertoli cell
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Male factor infertility is a significant concern throughout the world. The majority of the male infertility
cases are idiopathic. In the male, primordial germ cells (PGCs) migrate, proliferate, and colonize the
genital ridges to ultimately form testicular cords, where they establish contacts with the Sertoli cells. Key
factors that regulate primordial germ cell migration and proliferation are not completely understood. The
long-term goal of this project is to delineate the mechanisms of germ cell interactions with Sertoli cells in
the testis. A mechanistic understanding of how germ cells develop and function is relevant to clinical
conditions of male infertility that manifest as Sertoli cell-only syndrome for which there is currently no
treatment. To begin to explore the developmental biology of the male germ cells and to understand the
pathobiology of the human Sertoli cell-only syndrome, we have characterized atrichosis, the naturally
occurring homozygous recessive mouse mutant. The atrichosis mutant testis histology closely resembles
that of Sertoli cell-only syndrome patients and demonstrates tubules lined with only Sertoli cells and
contains no germ cells. We will test the central hypothesis that a cell autonomous defect leads to
complete absence of germ cells in the atrichosis mutant testis. These studies will identify the gene(s)
responsible for the absence of germ cells in the atrichosis mutant mouse and provide a starting point for
further loss-of-function and gain-of-function genetic approaches to understand germ cell migration and
function. Finally, this work will establish atrichosis mutant as a genetically trackable new mouse model for
human male infertility conditions associated with Sertoli cell-only tubules and germ cell aplasia, thus
impacting clinical protocols of male fertility restoration.
该副本是利用众多研究子项目之一
由NIH/NCRR资助的中心赠款提供的资源。子弹和
调查员(PI)可能已经从其他NIH来源获得了主要资金,
因此,可以在其他清晰的条目中表示。列出的机构是
对于中心,这不一定是调查员的机构。
男性因素不育是全世界的一个重大关注点。大多数男性不育
病例是特发性的。在雄性中,原始生殖细胞(PGC)迁移,增殖和定居
生殖脊最终形成睾丸绳,在那里与Sertoli细胞建立接触。钥匙
调节原始生殖细胞迁移和增殖的因素尚不完全了解。这
该项目的长期目标是描述生殖细胞与Sertoli细胞中的机理
睾丸。对生殖细胞如何发展和功能的机械理解与临床有关
雄性不育症的疾病表现为仅塞尔托利细胞综合征,目前没有
治疗。开始探索男性生殖细胞的发育生物学,并了解
人类仅细胞综合征的病理生物学,我们已经表征了荒谬,自然
发生纯合隐性小鼠突变体。术的突变睾丸组织学非常相似
仅Sertoli细胞综合征患者的病例,并展示了仅衬有Sertoli细胞和
没有生殖细胞。我们将测试中心假设,即细胞自主缺陷导致
术中术中完全不存在生殖细胞。这些研究将确定基因
负责术中缺乏生殖细胞,并为
进一步的功能丧失和功能获得的遗传方法,以了解生殖细胞迁移和
功能。最后,这项工作将建立萎缩突变体作为一种遗传跟踪的新鼠标模型
人类男性不育症条件与仅Sertoli细胞仅细胞小管和生殖细胞性相关,因此
影响男性生育恢复的临床方案。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
T. RAJENDRA KUMAR其他文献
T. RAJENDRA KUMAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('T. RAJENDRA KUMAR', 18)}}的其他基金
Gonadal and extra-gonadal actions of FSH glycoforms in aging
FSH 糖型在衰老过程中的性腺和性腺外作用
- 批准号:
9565031 - 财政年份:2017
- 资助金额:
$ 22万 - 项目类别:
Role of Dicer in Gonadotrope and Reproductive Function
Dicer 在促性腺激素和生殖功能中的作用
- 批准号:
8458899 - 财政年份:2012
- 资助金额:
$ 22万 - 项目类别:
Role of Dicer in Gonadotrope and Reproductive Function
Dicer 在促性腺激素和生殖功能中的作用
- 批准号:
8301917 - 财政年份:2012
- 资助金额:
$ 22万 - 项目类别:
相似国自然基金
MUC5B/Siglec途径对RA-ILD巨噬细胞胞葬的作用机制及临床价值研究
- 批准号:82302605
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MicroRNA-23a/HMGN2通过染色质重塑调控中性粒细胞抗细菌免疫的作用机制及其临床检测价值研究
- 批准号:82302630
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNF181通过泛素化降解LARP1抑制非小细胞肺癌的机制及临床意义
- 批准号:82360474
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
结外鼻型NK/T细胞淋巴瘤免疫特征分析与临床转化研究
- 批准号:82370199
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
NPTX1促进血管内皮细胞衰老在动脉粥样硬化中的作用机制及临床价值研究
- 批准号:82372302
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Causes and Downstream Effects of 14-3-3 Phosphorylation in Synucleinopathies
突触核蛋白病中 14-3-3 磷酸化的原因和下游影响
- 批准号:
10606132 - 财政年份:2024
- 资助金额:
$ 22万 - 项目类别:
Impact of tissue resident memory T cells on the neuro-immune pathophysiology of anterior eye disease
组织驻留记忆 T 细胞对前眼疾病神经免疫病理生理学的影响
- 批准号:
10556857 - 财政年份:2023
- 资助金额:
$ 22万 - 项目类别:
Gut microbiome-mediated differences within the pre-malignant mammary tissue environment enhance early breast tumor metastasis
恶变前乳腺组织环境中肠道微生物介导的差异增强了早期乳腺肿瘤转移
- 批准号:
10594667 - 财政年份:2023
- 资助金额:
$ 22万 - 项目类别:
Center of Research Translation on Osteoporosis Bone Anabolic Therapies
骨质疏松症骨合成代谢疗法研究转化中心
- 批准号:
10404412 - 财政年份:2023
- 资助金额:
$ 22万 - 项目类别:
Mechanisms of Parp inhibitor-induced bone marrow toxicities
Parp 抑制剂诱导骨髓毒性的机制
- 批准号:
10637962 - 财政年份:2023
- 资助金额:
$ 22万 - 项目类别: